PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

ramusmedical
news

Approving J&J’s new depression drug would be an unusual move for the FDA

The Food and Drug Administration would be making an unusual move if it greenlights Johnson & Johnson's experimental depression treatment, according to a briefing...
Continue Reading →
news

Merck kidney cancer data impresses, putting pressure on Bristol-Myers

Better-than-expected positive results from a late-stage study could position Merck & Co's immunotherapy Keytruda to play a large role in the treatment of metasta...
Continue Reading →
news

Stem cell transplant slows down MS progression

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple s...
Continue Reading →
Europe

New drug shows promise against several aggressive cancers

A new phase I/II open-label, dose-escalation trial has recently tested the effectiveness of a "Trojan horse" drug in treating multiple types of otherwise treatment-r...
Continue Reading →
Europe

Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss

AMSTERDAM, The Netherlands, February 05, 2019 / -- The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of the...
Continue Reading →
news

Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study

First presentation of data from the pivotal Phase III ARAMIS trial with the investigational compound darolutamide in patients with advanced prostate cancer that has ...
Continue Reading →
Europe

Sharp enhances IRT solution with latest investment

Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a $650,000 investment into enhancing its Intera...
Continue Reading →
Europe

CRF Bracket Becomes a Leading Employer in Romania Two Years after Establishing Office as Demand for Trustworthy Global Support of eClinical Solutions Continues to Grow

Plymouth Meeting, PA – February 6, 2019:  CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the...
Continue Reading →
Europe

FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

First medicine approved in the U.S. specifically for the treatment of aTTP, a rare blood-clotting disorderCablivi is the first U.S. approval for Sanofi's new rare bl...
Continue Reading →
news

From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Plymouth Meetin...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026